ScholarIQanswers from OpenAlex & ORCID
Frank W. Sellke
ResearcherPublications, citations & collaboration network
Frank W. Sellke is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Frank W. Sellke have?
ScholarIQindexed works
Frank W. Sellke has 905 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Frank W. Sellke have?
ScholarIQcitation count
Frank W. Sellke has 44,552 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Frank W. Sellke?
ScholarIQh-index
Frank W. Sellke has an h-index of 84 in OpenAlex.
What is the i10-index of Frank W. Sellke?
ScholarIQi10-index
Frank W. Sellke has an i10-index of 451 in OpenAlex.
What is the ORCID of Frank W. Sellke?
ScholarIQorcid
The ORCID for Frank W. Sellke is on the source record.
What is the OpenAlex record for Frank W. Sellke?
ScholarIQopenalex
The OpenAlex for Frank W. Sellke is on the source record.
What are the most-cited papers on Frank W. Sellke?
ScholarIQmost cited works
Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia
Sharon E. Maynard, Jiang-Yong Min, Jaime R. Merchan, Kee-Hak Lim, Jianyi Li, Susanta Mondal, Towia A. Libermann, James P. Morgan, Frank W. Sellke, Isaac E. Stillman, Franklin H. Epstein, Vikas P. Sukhatme, S. Ananth Karumanchi
Vascular Contributions to Cognitive Impairment and Dementia
Philip B. Gorelick, Angelo Scuteri, Sandra E. Black, Charles DeCarli, Steven M. Greenberg, Costantino Iadecola, Lenore J. Launer, Stéphane Laurent, Oscar L. Lopez, David L. Nyenhuis, Ronald C. Petersen, Julie A. Schneider, Christophe Tzourio, Donna K. Arnett, David A. Bennett, Helena C. Chui, Randall T. Higashida, Ruth Lindquist, Peter M. Nilsson, Gustavo C. Román, Frank W. Sellke, Sudha Seshadri
Soluble endoglin contributes to the pathogenesis of preeclampsia
Shivalingappa Venkatesha, Mourad Toporsian, Chun Sing Lam, Jun‐ichi Hanai, Tadanori Mammoto, Yeon M. Kim, Yuval Bdolah, Kee-Hak Lim, Haitao Yuan, Towia A. Libermann, Isaac E. Stillman, Drucilla J. Roberts, Patrìcia A. D'Amore, Franklin H. Epstein, Frank W. Sellke, Roberto Romero, Vikas P. Sukhatme, Michelle Letarte, S. Ananth Karumanchi
Post-cardiac arrest syndrome: Epidemiology, pathophysiology, treatment, and prognostication
Jerry P. Nolan, Robert W. Neumar, Christophe Adrie, Mayuki Aibiki, Robert A. Berg, Bernd W. Böttiger, Clifton W. Callaway, Robert S. B. Clark, Romergryko G. Geocadin, Edward C. Jauch, Karl B. Kern, Ivan Laurent, W. T. Longstreth, Raina M. Merchant, Peter T. Morley, Laurie J. Morrison, Vinay Nadkarni, Mary Ann Peberdy, Emanuel P. Rivers, Antonio Rodríguez‐Núñez, Frank W. Sellke, Christian Spaulding, Kjetil Sunde, Terry L. Vanden Hoek
Idarucizumab for Dabigatran Reversal
Charles V. Pollack, Paul A. Reilly, John W. Eikelboom, Stephan Glund, Peter Verhamme, Richard A. Bernstein, Robert Dubiel, Menno V. Huisman, Elaine M. Hylek, Pieter W. Kamphuisen, Jörg Kreuzer, Jerrold H. Levy, Frank W. Sellke, Joachim Stangier, Thorsten Steiner, Bushi Wang, CW Kam, Jeffrey I. Weitz